Atlas Trials

Study of Polyfunctionality of Anti-tumor T Lymphocytes in Cancerology: Potential Biomarker for Emerging Immunotherapies

Clinical trial NCT02880046 · UNKNOWN

Trial details

NCT number
NCT02880046
Sponsor
Central Hospital, Nancy, France
Status
UNKNOWN
Study type
OBSERVATIONAL
Cancer
Start date
2016-10-01
Primary completion
2017-10-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.